Formulary Monographs [CISPLATIN, 1000]
|
|
CISPLATIN
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Treatment of testicular, lung, cervical, bladder, head and neck, and ovarian cancer.
|
|
|
Alop ecia, bone-marrow suppression,extravasation, hyperuricaemia, hypomagnesaemia, myelosuppression, nephrotoxicity severe nausea, severe vomiting.
|
|
|
|
|
|
|
|
|
Cisplatin may cause fetal harm when administered to a pregnant woman but potential benefits from use of the drug may be acceptable in certain conditions despite possible risks to the fetus.
|
|
|
Cisplatin is distributed into milk. Nursing should be discontinued to avoid the potential for serious adverse reactions to cisplatin in nursing infants.
|
|
|
|